home / stock / bcyc / bcyc quote
Last: | $ |
---|---|
Change Percent: | 6.99% |
Open: | $12.80 |
Close: | $13.32 |
High: | $13.60 |
Low: | $11.975 |
Volume: | 23,074 |
Last Trade Date Time: | 02/12/2020 04:41:42 pm |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$ | $12.80 | $13.32 | $13.60 | $11.975 | 23,074 | 02-12-2020 |
$ | $13.97 | $12.45 | $13.98 | $12.24 | 44,358 | 02-11-2020 |
$ | $11.92 | $12.98 | $13.8999 | $11.8497 | 38,825 | 02-10-2020 |
$ | $11.58 | $11.76 | $12.18 | $11.58 | 5,163 | 02-07-2020 |
$ | $11.01 | $11.67 | $11.67 | $11.00 | 2,376 | 02-06-2020 |
$ | $10.98 | $10.85 | $11.11 | $10.85 | 1,823 | 02-05-2020 |
$ | $10.645 | $10.75 | $10.9095 | $10.54 | 5,937 | 02-04-2020 |
$ | $10.675 | $10.54 | $10.81 | $10.50 | 9,654 | 02-03-2020 |
$ | $10.725 | $10.7866 | $10.99 | $10.60 | 3,818 | 01-31-2020 |
$ | $11.00 | $10.98 | $11.00 | $10.6601 | 8,460 | 01-30-2020 |
$ | $11.067 | $11.00 | $11.1481 | $10.3647 | 5,316 | 01-29-2020 |
$ | $11.2745 | $11.20 | $11.2745 | $10.92 | 7,771 | 01-28-2020 |
$ | $11.0154 | $11.10 | $11.37 | $10.74 | 4,660 | 01-27-2020 |
$ | $11.4585 | $10.75 | $11.4585 | $10.73 | 15,385 | 01-24-2020 |
$ | $11.37 | $10.80 | $11.37 | $10.27 | 10,481 | 01-23-2020 |
$ | $11.7095 | $11.30 | $11.9112 | $11.1467 | 7,734 | 01-22-2020 |
$ | $11.30 | $11.48 | $11.48 | $10.7006 | 6,199 | 01-21-2020 |
$ | $11.20 | $11.20 | $11.2148 | $10.92 | 3,926 | 01-20-2020 |
$ | $11.20 | $11.20 | $11.2148 | $10.92 | 3,926 | 01-17-2020 |
$ | $11.00 | $11.20 | $11.30 | $11.00 | 1,665 | 01-16-2020 |
News, Short Squeeze, Breakout and More Instantly...
Bicycle Therapeutics plc Company Name:
BCYC Stock Symbol:
NYSE Market:
Bicycle Therapeutics plc (NASDAQ: BCYC), a biopharmaceutical company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (Bicycle ® ) technology, today announced the acceptance of two abstracts for poster presentation at the 2024 Amer...
Bicycle Therapeutics plc (NASDAQ: BCYC), a biopharmaceutical company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (Bicycle ® ) technology, today announced that management will participate in a fireside chat at the 23rd Annual N...
Bicycle Therapeutics plc (NASDAQ: BCYC), a biopharmaceutical company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (Bicycle ® ) technology, today announced the acceptance of three abstracts for poster presentation at the America...